NeuroOne Medical Technologies (NMTC) Competitors $0.60 -0.02 (-3.23%) Closing price 04:00 PM EasternExtended Trading$0.60 +0.00 (+0.58%) As of 07:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NMTC vs. ZJYL, OBIO, ICAD, GUTS, MGRM, MBOT, FONR, MLSS, SRTS, and INOShould you be buying NeuroOne Medical Technologies stock or one of its competitors? The main competitors of NeuroOne Medical Technologies include Jin Medical International (ZJYL), Orchestra BioMed (OBIO), iCAD (ICAD), Fractyl Health (GUTS), Monogram Orthopaedics (MGRM), Microbot Medical (MBOT), FONAR (FONR), Milestone Scientific (MLSS), Sensus Healthcare (SRTS), and Inovio Pharmaceuticals (INO). These companies are all part of the "medical equipment" industry. NeuroOne Medical Technologies vs. Jin Medical International Orchestra BioMed iCAD Fractyl Health Monogram Orthopaedics Microbot Medical FONAR Milestone Scientific Sensus Healthcare Inovio Pharmaceuticals Jin Medical International (NASDAQ:ZJYL) and NeuroOne Medical Technologies (NASDAQ:NMTC) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their community ranking, media sentiment, analyst recommendations, profitability, valuation, institutional ownership, dividends, risk and earnings. Which has more risk & volatility, ZJYL or NMTC? Jin Medical International has a beta of 12.24, meaning that its stock price is 1,124% more volatile than the S&P 500. Comparatively, NeuroOne Medical Technologies has a beta of 0.65, meaning that its stock price is 35% less volatile than the S&P 500. Is ZJYL or NMTC more profitable? Jin Medical International has a net margin of 0.00% compared to NeuroOne Medical Technologies' net margin of -82.17%. Jin Medical International's return on equity of 0.00% beat NeuroOne Medical Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Jin Medical InternationalN/A N/A N/A NeuroOne Medical Technologies -82.17%-270.70%-129.70% Does the MarketBeat Community believe in ZJYL or NMTC? NeuroOne Medical Technologies received 64 more outperform votes than Jin Medical International when rated by MarketBeat users. CompanyUnderperformOutperformJin Medical InternationalN/AN/ANeuroOne Medical TechnologiesOutperform Votes6471.91% Underperform Votes2528.09% Do insiders and institutionals have more ownership in ZJYL or NMTC? 16.1% of NeuroOne Medical Technologies shares are held by institutional investors. 8.9% of NeuroOne Medical Technologies shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Do analysts recommend ZJYL or NMTC? NeuroOne Medical Technologies has a consensus target price of $1.45, suggesting a potential upside of 129.43%. Given NeuroOne Medical Technologies' stronger consensus rating and higher possible upside, analysts clearly believe NeuroOne Medical Technologies is more favorable than Jin Medical International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Jin Medical International 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00NeuroOne Medical Technologies 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has preferable earnings & valuation, ZJYL or NMTC? Jin Medical International has higher revenue and earnings than NeuroOne Medical Technologies. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioJin Medical International$23.50M5.33$3.68MN/AN/ANeuroOne Medical Technologies$5.75M5.48-$12.32M-$0.22-2.87 Does the media favor ZJYL or NMTC? In the previous week, NeuroOne Medical Technologies had 2 more articles in the media than Jin Medical International. MarketBeat recorded 2 mentions for NeuroOne Medical Technologies and 0 mentions for Jin Medical International. NeuroOne Medical Technologies' average media sentiment score of 0.64 beat Jin Medical International's score of 0.00 indicating that NeuroOne Medical Technologies is being referred to more favorably in the news media. Company Overall Sentiment Jin Medical International Neutral NeuroOne Medical Technologies Positive SummaryNeuroOne Medical Technologies beats Jin Medical International on 9 of the 15 factors compared between the two stocks. Get NeuroOne Medical Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for NMTC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NMTC vs. The Competition Export to ExcelMetricNeuroOne Medical TechnologiesSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$31.49M$4.53B$5.40B$8.49BDividend YieldN/A43.65%5.22%4.11%P/E Ratio-2.4329.8226.7119.93Price / Sales5.4870.77395.44119.84Price / CashN/A51.0838.2534.62Price / Book6.326.316.854.59Net Income-$12.32M$68.16M$3.23B$248.19M7 Day Performance-4.24%21.03%5.35%2.21%1 Month Performance11.46%25.54%13.31%16.23%1 Year Performance-39.23%22.21%17.58%8.00% NeuroOne Medical Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NMTCNeuroOne Medical Technologies1.7303 of 5 stars$0.60-3.2%$1.45+141.1%-40.8%$29.97M$5.75M-2.3120Gap UpZJYLJin Medical InternationalN/A$0.80-0.8%N/A-74.2%$125.24M$23.50M0.00245OBIOOrchestra BioMed2.831 of 5 stars$2.87-1.7%$14.20+394.8%-43.6%$109.65M$2.89M-1.784Gap UpICADiCAD0.2843 of 5 stars$3.93-1.2%N/A+141.5%$108M$19.61M-30.27140News CoverageAnalyst ForecastGap UpGUTSFractyl Health1.6929 of 5 stars$2.10-1.2%$11.00+425.1%-69.9%$102.61M$93,000.00-0.17102MGRMMonogram Orthopaedics3.2412 of 5 stars$2.72+1.1%$5.40+98.5%+40.1%$95.99M$364,999.00-5.7928Earnings ReportGap UpMBOTMicrobot Medical1.6914 of 5 stars$2.76+0.6%$9.00+226.6%+162.1%$95.72MN/A-3.4420Positive NewsEarnings ReportGap UpFONRFONAR1.7871 of 5 stars$13.98+3.5%N/A-1.8%$86.83M$101.57M12.16480News CoveragePositive NewsEarnings ReportAnalyst UpgradeHigh Trading VolumeMLSSMilestone Scientific1.1407 of 5 stars$1.02flat$1.25+22.5%+46.9%$79.95M$8.63M-14.5730Analyst ForecastSRTSSensus Healthcare2.7132 of 5 stars$4.84+2.2%$11.67+141.3%-23.3%$79.75M$41.81M12.0940News CoverageEarnings ReportAnalyst ForecastAnalyst RevisionGap UpINOInovio Pharmaceuticals3.6613 of 5 stars$2.10+1.2%$9.75+365.4%-80.8%$76.87M$217,756.00-0.66320 Related Companies and Tools Related Companies ZJYL Competitors OBIO Competitors ICAD Competitors GUTS Competitors MGRM Competitors MBOT Competitors FONR Competitors MLSS Competitors SRTS Competitors INO Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NMTC) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMan who predicted $100K Bitcoin sees a huge run coming for another coin …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeuroOne Medical Technologies Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeuroOne Medical Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.